Predictive markers of colorectal cancer liver metastases.

Future Oncol 2011 Feb;7(2):299-307

Department of Surgery, Memorial Sloan-Kettering Cancer Center, 444 E 68th Street, New York, NY 10065, USA.

Liver metastases are the most common site of distant failure after curative resection of colorectal cancer and a source of significant cancer-related morbidity and mortality. Currently, imaging and conventional histopathologic features, such as T-stage and N-stage, are used by clinicians to inform prognosis and guide adjuvant treatment to reduce the risk of developing distant metastases. However, these tools only have a moderate ability to predict the development of liver metastases. Novel methods, including the detection of circulating tumor cells and carcinoembryonic antigens in serum, have been developed, and their prognostic and predictive characteristics have been assessed. In addition, several molecular and genetic markers in the primary tumor have been studied. Unfortunately, these studies are often small and their results have been mixed, yielding no consistent sets of externally validated predictors of colorectal liver metastases. For widespread clinical relevance, future tests need to be independently carried out on large independent patient samples.

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.10.184DOI Listing
February 2011
20 Reads

Publication Analysis

Top Keywords

liver metastases
16
colorectal cancer
8
metastases
5
serum developed
4
antigens serum
4
carcinoembryonic antigens
4
circulating tumor
4
tumor cells
4
cells carcinoembryonic
4
developed prognostic
4
assessed addition
4
addition molecular
4
characteristics assessed
4
predictive characteristics
4
prognostic predictive
4
detection circulating
4
metastases novel
4
distant metastases
4
metastases tools
4
developing distant
4

References

(Supplied by CrossRef)

Uen et al.
Ann. Surg. Oncol. 2008

Similar Publications